Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03300544
What this trial is testing

Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer

Who this might be right for
Locally Advanced Rectal AdenocarcinomaMetastatic Rectal AdenocarcinomaRectal Adenocarcinoma+7 more
National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT00028626
What this trial is testing

Portal Vein Embolization in Treating Patients With Liver Metastases From Primary Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT07001085
What this trial is testing

CtDNA Monitoring in Patients With HCC and mCRC

Who this might be right for
HCC - Hepatocellular CarcinomaColorectal Cancer Metastatic
Medical University of Warsaw 300
Early research (Phase 1)Active Not RecruitingNCT06818812
What this trial is testing

Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Who this might be right for
Solid Tumors
Incyte Corporation 30
Testing effectiveness (Phase 2)WithdrawnNCT03982173
What this trial is testing

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Who this might be right for
Metastatic Colorectal CancerTriple Negative Breast CancerProstate Adenocarcinoma+2 more
Gustave Roussy, Cancer Campus, Grand Paris
Testing effectiveness (Phase 2)Ended earlyNCT00006037
What this trial is testing

Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Southern California 18
Testing effectiveness (Phase 2)Study completedNCT00022698
What this trial is testing

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 67
Testing effectiveness (Phase 2)Study completedNCT00258232
What this trial is testing

Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT03798626
What this trial is testing

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

Who this might be right for
Colorectal CancerGastroesophageal CancerRenal Cell Carcinoma
Novartis Pharmaceuticals 167
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Large-scale testing (Phase 3)Study completedNCT00004885
What this trial is testing

Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 430
Not applicableEnded earlyNCT02363647
What this trial is testing

Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer

Who this might be right for
Medullary Thyroid CancerColon Cancer
Icahn School of Medicine at Mount Sinai 10
Large-scale testing (Phase 3)UnknownNCT00003260
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 109
Testing effectiveness (Phase 2)Study completedNCT01652196
What this trial is testing

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+3 more
John Hays 56
Testing effectiveness (Phase 2)Study completedNCT00419159
What this trial is testing

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Who this might be right for
Colorectal Cancer
Novartis Pharmaceuticals 199
Testing effectiveness (Phase 2)Study completedNCT00290615
What this trial is testing

Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Herbert Hurwitz 30
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT03428958
What this trial is testing

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+2 more
NuCana plc 111
Not applicableWithdrawnNCT04511793
What this trial is testing

Hepatic Artery Infusion (HAI) Program at Duke University

Who this might be right for
Metastatic Colon CancerLiver CancerIntrahepatic Cholangiocarcinoma
Michael Lidsky, M.D.
Testing effectiveness (Phase 2)Ended earlyNCT00005944
What this trial is testing

Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic CancerPrimary Peritoneal Cavity Cancer
UNICANCER
Next Page